Influence of pH on the prostacyclin (PGI2) mediated inhibition of platelet function
- 15 April 1980
- journal article
- Published by Elsevier in Prostaglandins and Medicine
- Vol. 4 (4), 263-273
- https://doi.org/10.1016/0161-4630(80)90021-x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different speciesProstaglandins, 1978
- Prostacyclin is a circulating hormoneNature, 1978
- Reversal of platelet aggregation by prostacyclinPharmacological Research Communications, 1978
- A synthesis of prostacyclin sodium saltTetrahedron Letters, 1977
- Synthesis and stereochemistry of prostacyclin and synthesis of 6-ketoprostaglandin F1.alpha.Journal of the American Chemical Society, 1977
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Prostaglandins, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- The chemical structure of prostaglandin X (prostacyclin)Prostaglandins, 1976
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976